Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
Recent Share tips:
- Sell URU Metals Ltd. (DI) (URU) by Nigel Somerville in ShareProphets
- Sell Trafalgar Property Group (TRAF) by Nigel Somerville in ShareProphets
- Sell AIQ Limited (DI) (AIQ) by Nigel Somerville in ShareProphets
- Speculative Buy Petrofac Ltd. (PFC) by Jabran Khan in The Motley Fool
- Sell Barkby Group (BARK) by Nigel Somerville in ShareProphets
- Sell Tern (TERN) by Nigel Somerville in ShareProphets
- Buy Unite Group (UTG) by Jabran Khan in The Motley Fool
- Buy NewRiver REIT (NRR) by Jabran Khan in The Motley Fool
- Add Hargreaves Lansdown (HL.) by Dr. James Fox in The Motley Fool
- Buy National Grid (NG.) by Jon Smith in The Motley Fool
- Buy AstraZeneca (AZN) by Dr. James Fox in The Motley Fool
- Buy IG Group Holdings (IGG) by Jon Smith in The Motley Fool
- Neutral Ocado Group (OCDO) by JP Morgan
- Overweight Melrose Industries (MRO) by JP Morgan
- Outperform Alliance Pharma (APH) by RBC Capital
- Buy SEGRO (SGRO) by Citi
- Outperform Oxford Nanopore Technologies (ONT) by RBC Capital
- Overweight London Stock Exchange Group (LSEG) by Barclays
- Overweight Glencore (GLEN) by Barclays
- Overweight Capita (CPI) by Barclays
Vectura Group (VEC)
Health Care Sector
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Vectura Group Overview
Vectura develops inhaled therapies principally for the treatment of respiratory diseases. Inhaled formulation development is increasingly complex with a wide variety of small molecules and biologics, increasing use of combination products and the need for targeted lung delivery or deep lung deposition for systemic delivery. We offer formulation services for DPI, pMDI and nebuliser development, including small molecules and biologics, complex combinations and generic products.Latest Vectura Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Peel Hunt | – | 2021-07-09 10:25:00 09/07/2021 | – |
| – | Shore Capital | – | 2021-05-26 18:00:00 26/05/2021 | – |
| – | Panmure Gordon | – | 2021-05-26 14:25:00 26/05/2021 | – |
| – | Peel Hunt | – | 2021-05-26 11:10:00 26/05/2021 | – |
| – | JP Morgan | – | 2021-03-19 07:30:00 19/03/2021 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Vectura Group Overview
Vectura develops inhaled therapies principally for the treatment of respiratory diseases. Inhaled formulation development is increasingly complex with a wide variety of small molecules and biologics, increasing use of combination products and the need for targeted lung delivery or deep lung deposition for systemic delivery. We offer formulation services for DPI, pMDI and nebuliser development, including small molecules and biologics, complex combinations and generic products.Latest Vectura Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Peel Hunt | – | 2021-07-09 10:25:00 09/07/2021 | – |
| – | Shore Capital | – | 2021-05-26 18:00:00 26/05/2021 | – |
| – | Panmure Gordon | – | 2021-05-26 14:25:00 26/05/2021 | – |
| – | Peel Hunt | – | 2021-05-26 11:10:00 26/05/2021 | – |
| – | JP Morgan | – | 2021-03-19 07:30:00 19/03/2021 | – |